We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+15.3%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$7.03B
AUM Growth
+$26.4M
Cap. Flow
-$519M
Cap. Flow %
-7.37%
Top 10 Hldgs %
20.05%
Holding
2,389
New
775
Increased
418
Reduced
541
Closed
635

Sector Composition

Rank Sector Weight
1 Technology 12.71%
2 Healthcare 8.19%
3 Financials 7.23%
4 Industrials 7.01%
5 Consumer Discretionary 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY.RT
1676
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$69K ﹤0.01%
100,099
-50,000
-33% -$107K
WHWK
1677
Whitehawk Therapeutics
WHWK
$183M
$67K ﹤0.01%
4,536
-12,452
-73% -$266K
VXRT
1678
DELISTED
Vaxart
VXRT
$66K ﹤0.01%
+11,636
New +$74K
DIV icon
1679
Global X SuperDividend US ETF
DIV
$787M
$65K ﹤0.01%
+3,830
New +$62K
IWS icon
1680
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$64K ﹤0.01%
661
-122,942
-99% -$11.1M
VKTX icon
1681
Viking Therapeutics
VKTX
$4.05B
$63K ﹤0.01%
11,157
-10,415
-48% -$63.1K
KG
1682
Kestrel Group
KG
$70.1M
$62K ﹤0.01%
+1,248
New +$42.9K
INFI
1683
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$62K ﹤0.01%
29,087
-91,781
-76% -$151K
LXU icon
1684
LSB Industries
LXU
$824M
$60K ﹤0.01%
22,906
+4,459
+24% +$8.1K
HTGM
1685
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$58K ﹤0.01%
1,003
-2,248
-69% -$131K
CENT icon
1686
Central Garden & Pet Co
CENT
$2.71B
$57K ﹤0.01%
1,830
+681
+59% +$21.8K
DVY icon
1687
iShares Select Dividend ETF
DVY
$23.8B
$57K ﹤0.01%
+593
New +$53.8K
BLCM
1688
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$56K ﹤0.01%
15,760
-25,601
-62% -$108K
RLH
1689
DELISTED
Red Lions Hotel Corporation
RLH
$56K ﹤0.01%
16,289
+3,063
+23% +$6.88K
IJH icon
1690
iShares Core S&P Mid-Cap ETF
IJH
$123B
$54K ﹤0.01%
+1,175
New +$49.5K
SPPI
1691
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$53K ﹤0.01%
15,400
-37,622
-71% -$155K
APTO
1692
DELISTED
Aptose Biosciences, Inc.
APTO
$53K ﹤0.01%
+27
New +$63.4K
SMTX
1693
DELISTED
SMTC Corporation
SMTX
$51K ﹤0.01%
10,184
-9,055
-47% -$37.6K
AAXJ icon
1694
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.66B
$49K ﹤0.01%
+552
New +$46.2K
CNVS icon
1695
Cineverse
CNVS
$58.8M
$49K ﹤0.01%
3,776
-6,500
-63% -$79.1K
MUX icon
1696
McEwen Inc
MUX
$1.04B
$49K ﹤0.01%
+4,984
New +$50.9K
NINE
1697
DELISTED
Nine Energy Service
NINE
$48K ﹤0.01%
17,512
+6,130
+54% +$11.3K
IQLT icon
1698
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
$46K ﹤0.01%
+1,301
New +$43.5K
NMTR
1699
DELISTED
9 Meters Biopharma
NMTR
$46K ﹤0.01%
2,682
-8,930
-77% -$149K
DHF
1700
BNY Mellon High Yield Strategies Fund
DHF
$170M
$45K ﹤0.01%
14,900

Similar funds

Qube Research & Technologies (QRT)'s Q4 2020 Portfolio in Review

As of Q4 2020, Qube Research & Technologies (QRT) held 2,389 positions worth $7.03B, up 0.38% from $7.01B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Qube Research & Technologies (QRT) withdrew a net $519M in Q4 2020, closing 635 positions and reducing 541 holdings. Its most notable exit was iShares 7-10 Year Treasury Bond ETF, an estimated $57.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Qube Research & Technologies (QRT) opened a new position in Vanguard Intermediate-Term Corporate Bond ETF worth $174M.

  • Qube Research & Technologies (QRT)'s largest Q4 2020 buy was Vanguard Intermediate-Term Corporate Bond ETF: 1,795,854 shares worth $174M.
  • Qube Research & Technologies (QRT) added most to iShares National Muni Bond ETF in Q4 2020, an estimated $105M increase.
  • Qube Research & Technologies (QRT)'s biggest Q4 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $127M.
  • Qube Research & Technologies (QRT) fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2020, selling an estimated $57.9M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 20% of its $7.03B portfolio in Q4 2020.
  • Qube Research & Technologies (QRT) opened 775 new positions and closed 635 in Q4 2020.
  • Qube Research & Technologies (QRT)'s portfolio value rose 0.38% quarter-over-quarter to $7.03B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.